La Jolla Pharmaceutical Q3 EPS $(0.08) Up From $(0.43) YoY, Sales $13.31M Up From $9.07M YoY
La Jolla Pharmaceutical (NASDAQ:LJPC) reported quarterly losses of $(0.08) per share. This is a 81.4 percent increase over losses of $(0.43) per share from the same period last year. The company reported $13.31 million
La Jolla Pharmaceutical Q2 EPS $0.11 Up From $(0.57) YoY, Sales $16.06M Up From $5.80M YoY
La Jolla Pharmaceutical (NASDAQ:LJPC) reported quarterly earnings of $0.11 per share. This is a 119.3 percent increase over losses of $(0.57) per share from the same period last year. The company reported $16.06 million
46 Stocks Moving In Thursday’s Mid-Day Session
Gainers
GTT Communications, Inc. (NYSE: GTT) shares jumped 66% to $4.16 on abnormally-high volume. The company’s stock also jumped over 57% on Wednesday.
60 Biggest Movers From Yesterday
Gainers
Lizhi Inc. (NASDAQ: LIZI) shares surged 57.6% to close at $6.84 on Wednesday.
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 13)